Beijing Establishes New Drug Innovation And Production Alliance
This article was originally published in PharmAsia News
Executive Summary
To accelerate the commercialization of pharmaceutical technology and reverse the low market share of Beijing-made drugs, Peking University, Beijing Pharmaceutical Group, Beijing Pharmaceutical Profession Association and 13 other Beijing-based biopharmaceutical institutions have officially formed an industry research alliance. Based on an open system, the enterprises and academic institutions will bring in more organizations to co-develop innovative products within the group. The alliance will focus on setting up a platform in four areas: new drug pilots, guidance for clinical trials, new product R&D and commercialization, and talent cultivation. (Click here for more - Chinese Language)